The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
Open accessAbstract
The efficiency of first-generation adenoviral vectors as gene delivery tools is often limited by the short duration of transgene expression, which can be related to immune responses and to toxic effects of viral proteins. In addition, readministration is usually ineffective unless the animals are immunocompromised or a different adenovirus serotype is used. Recently, adenoviral vectors devoid of all viral coding sequences (helper-dependent or gutless vectors) have been developed to avoid expression of viral proteins. In mice, liver-directed gene transfer with AdSTK109, a helper-dependent adenoviral (Ad) vector containing the human α 1 -antitrypsin (hAAT) gene, resulted in sustained expression for longer than 10 months with negligible toxicity to the liver. In the present report, we have examined the duration of expression of AdSTK109 in the liver of baboons and compared it to first-generation vectors expressing hAAT. Transgene expression was limited to approximately 3–5 months with the first-generation vectors. In contrast, administration of AdSTK109 resulted in transgene expression for longer than a year in two of three baboons. We have also investigated the feasibility of circumventing the humoral response to the virus by sequential administration of vectors of different serotypes. We found that the ineffectiveness of readministration due to the humoral response to an Ad5 first-generation vector was overcome by use of an Ad2-based vector expressing hAAT. These data suggest that long-term expression of transgenes should be possible by combining the reduced immunogenicity and toxicity of helper-dependent vectors with sequential delivery of vectors of different serotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Construction of adenovirus vectors through Cre-lox recombination
Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., & Phipps, M. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1842-1849.1997 · Cited by 789
Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo
Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 737
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Self-citationSchiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
Self-citationTripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Self-citationInnate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Adenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Muruve, D. A., Barnes, M. J., Stillman, I. E., & Libermann, T. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950018364 · Cited by 447
Morsy, M. A., Gu, M., Motzel, S., Zhao, J., Lin, J., Su, Q., Allen, H., Franlin, L., Parks, R. J., Graham, F. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7866 · Cited by 365
Self-citationAdenovirus mediated expression of therapeutic plasma levels of human factor IX in mice
Smith, T. A. G., Mehaffey, M. G., Kayda, D. B., Saunders, J. M., Yei, S., Trapnell, B. C., McClelland, A., & Kaleko, M. (1993) · Nature Genetics · doi:10.1038/ng1293-397 · Cited by 335
Huard, J., Lochmüller, H., Acsádi, G., Jani, A., Massie, B., & Karpati, G. (1995) · PubMed · Cited by 331
Stratford-Perricaudet, L. D., Levrero, M., Chasse, J.-F., Perricaudet, M., & Briand, P. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.3-241 · Cited by 325
Adenovirus as an expression vector in muscle cells in vivo.
Quantin, B., Perricaudet, L. D., Tajbakhsh, S., & Mandel, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2581 · Cited by 296
Persistence in muscle of an adenoviral vector that lacks all viral genes
Chen, H.-H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., & Clemens, P. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1645 · Cited by 291
Self-citationRecombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis
FISHER, K. J., CHOI, H., BURDA, J., CHEN, S.-J., & WILSON, J. M. (1996) · Virology · doi:10.1006/viro.1996.0088 · Cited by 291
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 279
Adenovirus-mediated regulable target gene expression in vivo
Burcin, M. M., Schiedner, G., Kochanek, S., Tsai, S. Y., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.355 · Cited by 249
Self-citationMorral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. L., Kochanek, S., & Beaudet, A. L. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2709 · Cited by 245
Self-citationKafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L., & Verma, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11377 · Cited by 244
Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D. H., Alvira, M. R., Buttrick, P. M., & Leinwand, L. A. (1994) · PubMed · Cited by 216
Lieber, A., He, C. Y., Kirillova, I., & Kay, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8944-8960.1996 · Cited by 211
Wolff, G., Worgall, S., van Rooijen, N., Song, W. R., Harvey, B. G., & Crystal, R. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.624-629.1997 · Cited by 210
Mastrangeli, A., Harvey, B.-G., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G., & Falck-Pedersen, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-79 · Cited by 204
Engelhardt, J. F., Simon, R. H., Yang, Y., Zepeda, M., Weber-Pendleton, S., Doranz, B., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-759 · Cited by 195
Mack, C. A., Song, W.-R., Carpenter, H., Wickham, T. J., Kovesdi, I., Harvey, B.-G., Magovern, C. J., Isom, O. W., Rosengart, T., Falck-Pedersen, E., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-99 · Cited by 192
Human Adenovirus Vectors for Gene Transfer into Mammalian Cells
Hitt, M. M., Addison, C. L., & Graham, F. L. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60140-4 · Cited by 186
Self-citationEffect of the E4 region on the persistence of transgene expression from adenovirus vectors
Armentano, D., Zabner, J., Sacks, C., Sookdeo, C. C., Smith, M. P., St George, J. A., Wadsworth, S. C., Smith, A. E., & Gregory, R. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2408-2416.1997 · Cited by 185
Self-citationKozarsky, K. E., Jooss, K., Donahee, M., Strauss, J. F., & Wilson, J. M. (1996) · Nature Genetics · doi:10.1038/ng0596-54 · Cited by 178
Kumar-Singh, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.913 · Cited by 175
Morral, N., O'Neal, W., Zhou, H., Langston, C., & Beaudet, A. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.10-1275 · Cited by 170
Self-citationHaecker, S. E., Stedman, H. H., Balice‐Gordon, R. J., Smith, D. B. J., Greelish, J. P., Mitchell, M. A., Wells, A. L., Sweeney, H. L., & Wilson, J. M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.15-1907 · Cited by 146
O’Neal, W. K., Zhou, H., Morral, N., Aguilar-Córdova, E., Pestaner, J. P., Langston, C., Mull, B. B., Wang, Y., Beaudet, A. L., & Lee, B. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.11-1587 · Cited by 135
Self-citationCircumventing the immune response to adenovirus-mediated gene therapy.
Kass-Eisler, A., Leinwand, L. A., Gall, J. G. D., Bloom, B., & Falck-Pedersen, E. (1996) · PubMed · Cited by 134
Yang, Y., Greenough, K., & Wilson, J. M. (1996) · PubMed · Cited by 131
Smith, T. A., White, B. D., Gardner, J. M., Kaleko, M., & McClelland, A. (1996) · PubMed · Cited by 126
Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
Jooss, K. U., Turka, L., & Wilson, J. M. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300595 · Cited by 125
Parks, R. J., Evelegh, C. M., & Graham, F. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300995 · Cited by 122
Self-citationKumar‐Singh, R., & Farber, D. B. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.12.1893 · Cited by 118
Piedra, P. A., Poveda, G. A., Ramsey, B. W., McCoy, K., & Hiatt, P. (1998) · PEDIATRICS · doi:10.1542/peds.101.6.1013 · Cited by 115
Self-citationKay, M. A., Graham, F. L., Leland, F. E., & Woo, S. L. C. (1995) · Hepatology · doi:10.1002/hep.1840210331 · Cited by 107
Self-citationPeeters, M.-J. T. F. D. V., Lieber, A., Perkins, J. D., et al. (1996) · BioTechniques · doi:10.2144/96202rr05 · Cited by 103
Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre
Chen, L., Anton, M., & Graham, F. L. (1996) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02369439 · Cited by 100
Self-citationZhou, H., O’Neal, W. K., Morral, N., & Beaudet, A. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7030-7038.1996 · Cited by 95
Self-citationKuz'min, A. N., Finegold, M. J., & Eisensmith, R. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300377 · Cited by 94
Extensive Cross-Reactivity of Adenovirus-Specific Cytotoxic T Cells
Smith, C. A., Woodruff, L. S., Rooney, C. M., & Kitchingman, G. R. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.10-1419 · Cited by 93
Brough, D. E., Hsu, C., Kulesa, V., Lee, G. M., Cantolupo, L. J., Lizonová, A., & Kovesdi, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9206-9213.1997 · Cited by 91
Sustained expression of therapeutic levels of human factor VIII in mice
Connelly, S., Gardner, J., Lyons, R., McClelland, A., & Kaleko, M. (1996) · Blood · doi:10.1182/blood.v87.11.4671.bloodjournal87114671 · Cited by 90
Development of Replication-Defective Herpes Simplex Virus Vectors
Krisky, D. M., Marconi, P., Goins, W. F., & Glorioso, J. C. (2003) · Humana Press eBooks · doi:10.1385/0-89603-484-4:79 · Cited by 71
Cited by
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
Update on adenovirus and its vectors
Russell, W. C. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2573 · Cited by 596
Gene therapy: trials and tribulations
Somia, N., & Verma, I. M. (2000) · Nature Reviews Genetics · doi:10.1038/35038533 · Cited by 554
Metadata
- Authors
- Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., Wadsworth, S., Graham, F. L., Kochanek, S., Carey, K. D., & Beaudet, A. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-10-26
- Volume
- 96
- Issue
- 22
- Pages
- 12816-12821
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2160690575
- Cited by
- 409
- References
- 51
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.